Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many women were admitted to hospital with ovarian hyperstimulation syndrome in each of the last five years for which figures are available; how many adverse incidents were recorded in licensed clinics in that period; and what the severity grading of each such incident was.
Answered by Jane Ellison
The Human Fertilisation and Embryology Authority (HFEA) has advised that the data it holds on these issues is as follows:
Year | Total number of incidents reported | Severity: Grade A | Severity: Grade B | Severity: Grade C | Not an incident/near miss |
2009-10 | 497 | 7 | 308 | 146 | 36 |
2010-11 | 586 | 1 | 292 | 255 | 38 |
2011-12 | 571 | 3 | 206 | 308 | 54 |
2012-13 | 503 | 0 | 183 | 261 | 59 |
2013-14 | 506 | 4 | 203 | 255 | 44 |
Of these, the number of cases of Ovarian Hyperstimulation Syndrome (OHSS) reported to the Authority is as follows:
Years | Number of OHSS | Moderate | Severe |
2009-10 | 121 | 1 | 120 |
2010-11 | 221 | 122 | 99 |
2011-12 | 241 | 196 | 45 |
2012-13 | 179 | 134 | 45 |
2013-14 | 192 | 142 | 50 |
The HFEA has also advised that licensed fertility clinics are only required to report instances of OHSS to the Authority that require a hospital admission with a severe grading, although in practice clinics often report moderate OHSS as well.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, in how many of licensable treatment cycles at least 20 eggs were collected in the last five years for which figures are available.
Answered by Jane Ellison
The information requested in shown in the following table:
Years | Licensable treatment cycles where at least 20 eggs were collected |
2008 | 2,910 |
2009 | 3,095 |
2010 | 3,435 |
2011 | 3,466 |
2012 | 3,464 |
20131 | 1,764 |
Note:
1The year 2013 only covers the period 1 January to 30 June 2013.
Source: The Human Fertilisation and Embryology Authority
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to the Answer of 19 January 2012, Official Report, columns 932-3W, how many companies hold licences for the manufacture or distribution of (a) Nitrazepam, (b) Flurazepam, (c) Loprazolam, (d) Lormetazepam, (e) Temazepam, (f) Clonazepam, (g) Medazepam, (h) Midazolam, (i) Zopiclone, (j) Zaleplon, (k) Zolpiden, (l) Eszopiclone, (m) SSRI antidepressants and (n) trycyclic antidepressants; and how many of those licences were issued in the last three years.
Answered by Norman Lamb
There are currently 15 products authorised in the United Kingdom containing nitrazepam and 15 different companies authorised to manufacture and distribute them.
There are currently two products authorised in the UK containing flurazepam and one company authorised to manufacture and distribute them.
There are currently two products authorised in the UK containing loprazolam and two different companies authorised to manufacture and distribute them.
There are currently eight products authorised in the UK containing lormetazepam and four different companies authorised to manufacture and distribute them.
There are currently 10 products authorised in the UK containing temazepam and six different companies authorised to manufacture and distribute them.
There are currently six products authorised in the UK containing clonazepam and three different companies authorised to manufacture and distribute them.
There are currently no authorised products in the UK containing medazepam.
There are currently 22 products authorised in the UK containing midazolam and 10 different companies authorised to manufacture and distribute them.
There are currently 17 products authorised in the UK containing zopiclone and nine different companies authorised to manufacture and distribute them.
There are currently two products authorised in the UK containing zaleplon and one company authorised to manufacture and distribute them.
There are currently 21 products authorised in the UK containing zolpidem and 12 different companies authorised to manufacture and distribute them.
There are currently no authorised products in the UK containing eszopiclone.
There are currently 238 products authorised in the UK containing SSRI antidepressants and 57 different companies authorised to manufacture and distribute them.
There are currently 16 products authorised in the UK containing tricyclic antidepressants and 11 different companies authorised to manufacture and distribute them.
One loprazolam, four lormetazepam, two clonazepam, two midazolam, three zopiclone, four zolpidem and 75 SSRI products have been authorised in the last three years.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many people in England in receipt of free social care are terminally ill.
Answered by Norman Lamb
Local authorities have a duty to assess the needs of any person for whom the authority may arrange social care and who may be in need of such care. They have a further duty to decide, having regard to the results of the assessment, what, if any, care and support they should provide to meet the individual's needs. Where a local authority decides to arrange care and support it will carry out a financial assessment to decide what an individual can afford to contribute towards the cost. Appeals against decisions by local authorities are considered locally. Information about appeals is not collected centrally.
In its 2011 report, the independent Palliative Care Funding Review recommended the provision of free social care at the end of life. A series of palliative care funding pilots were established to test the review's recommendations, and these completed their work in March 2014. NHS England is currently analysing the financial data collected from the pilots. Once this analysis has been completed, a decision will be made on the issue of free social care at the end of life, taking into account this analysis and wider policy and financial considerations.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many appeals were made by applicants for social care at the end of their life in the last two years; how many such appeals were successful; and what proportion of total appeals against decisions about social care such appeals represent.
Answered by Norman Lamb
Local authorities have a duty to assess the needs of any person for whom the authority may arrange social care and who may be in need of such care. They have a further duty to decide, having regard to the results of the assessment, what, if any, care and support they should provide to meet the individual's needs. Where a local authority decides to arrange care and support it will carry out a financial assessment to decide what an individual can afford to contribute towards the cost. Appeals against decisions by local authorities are considered locally. Information about appeals is not collected centrally.
In its 2011 report, the independent Palliative Care Funding Review recommended the provision of free social care at the end of life. A series of palliative care funding pilots were established to test the review's recommendations, and these completed their work in March 2014. NHS England is currently analysing the financial data collected from the pilots. Once this analysis has been completed, a decision will be made on the issue of free social care at the end of life, taking into account this analysis and wider policy and financial considerations.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he has made of the findings of the recent Global Forum on Incontinence into improving health and social care in incontinence.
Answered by Norman Lamb
No assessment has been made of the findings of the recent Global Forum on Incontinence (GFI) into improving health and social care in incontinence. However, we applaud the work of the GFI and the work it is doing to improve the health and social care provisions for incontinence, giving patients and care givers a better quality of life.
Responsibility for continence services sit with NHS England and clinical commissioning groups (CCG). CCGs are responsible for commissioning high quality continence services based on an assessment of local need and performance managing their providers in the delivery of high quality services.
The Mandate to NHS England requires it to deliver continued improvements in relation to enhancing the quality of life for people with long-term conditions, including those suffering incontinence, across the five domains of the NHS Outcomes Framework. NHS England will be taking forward a major programme of work through the Primary Care Strategy; it has established a working group on continence care and will provide an update for the All Party Parliamentary Group for Continence Care on 24 June.
To improve standards in continence care, the Department commissioned the National Institute for Health and Care Excellence (NICE) to develop clinical guidelines on the management of urinary incontinence in women (issued in 2006) and faecal incontinence in adults (issued in 2007), which are supported by commissioning tools to support CCGs. In February, NICE published a clinical Quality Standard on Faecal Incontinence, QS54, which describes high-priority areas for quality improvement in this area. NHS England continues to champion the use of Quality Standards with both commissioners and providers.
We believe all patients have the right to be treated with dignity, respect and compassion.
We recognise that continence can impact on every aspect of peoples' lives and that it often requires a joined approach from both health and social care services. That is why in April the Department published the policy paper, Transforming Primary Care: safe proactive, personalised care for those who need it, which focuses on improving and individualising the management of out of hospital care, directly supporting those with continence problems by creating more integrated health and social care services. This paper has been placed in the Library.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will discuss with the Royal College of Obstetricians and Gynaecologists the decision of its faculty of sexual and reproductive health not to allow doctors and nurses who have a conscientious objection to supplying contraceptive drugs or devices which act after fertilisation to receive its diploma in sexual and reproductive health.
Answered by Jane Ellison
The Faculty of Sexual and Reproductive Healthcare is responsible for decisions on the syllabus of its Diploma, the requirements for entry to the Diploma course, and the award of a Diploma qualification.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will take steps to ensure that the Faculty of Sexual and Reproductive Health of the Royal College of Obstetricians and Gynaecologists acts to accommodate doctors and nurses who have a conscientious objection to supplying contraceptive drugs or devices which act after fertilisation receive a diploma in sexual and reproductive health.
Answered by Jane Ellison
The Faculty of Sexual and Reproductive Healthcare are responsible for decisions on the syllabus of their Diploma, the requirements for entry to the Diploma course, and the award of a Diploma qualification.
The Department understands that their guidelines on the syllabus and on possible conscientious objection have not changed.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what his policy is on allowing doctors and nurses who have a conscientious objection to supplying contraceptive drugs or devices which act after fertilisation to receive diplomas in sexual and reproductive health.
Answered by Jane Ellison
The Faculty of Sexual and Reproductive Healthcare are responsible for decisions on the syllabus of their Diploma, the requirements for entry to the Diploma course, and the award of a Diploma qualification.
The Department understands that their guidelines on the syllabus and on possible conscientious objection have not changed.
Asked by: Jim Dobbin (Labour (Co-op) - Heywood and Middleton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 16 July 2013, Official Report, column 1667W, on drugs: poisoning, how many (a) men, (b) women and (c) children were admitted to hospital for drug poisoning, showing ICD10 codes T36-T50 separately at a four character level in 2013.
Answered by Jane Ellison
The information requested has been placed in the Library. It provides a count of the number of finished admission episodes with a primary diagnosis of T36-T50 for male and female adults and children for the year 2012-13. Explanatory footnotes have also been provided.
It should be noted that this is not a count of patients as the same patient may have been admitted more than once in a year.